Skip to main content
Figure 4 | Cancer Cell International

Figure 4

From: Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A

Figure 4

Growth inhibition by ruxolitinib in HT93A cells. After treatment for 7 days, growth inhibition was determined by trypan blue exclusion assay. Ruxolitinib inhibits cell growth in a dose-dependent manner. More than 320 nM ruxolitinib significantly inhibited growth. Experiments were independently repeated three times and results are shown as mean ± SD. *p < 0.05 vs. control.

Back to article page